| Year |
Citation |
Score |
| 2023 |
Habbit NL, Anbiah B, Suresh J, Anderson L, Davies ML, Hassani I, Ghosh TM, Greene MW, Prabhakarpandian B, Arnold RD, Lipke EA. Ratiometric Inclusion of Fibroblasts Promotes Both Castration-Resistant And Androgen-Dependent Tumorigenic Progression in Engineered Prostate Cancer Tissues. Advanced Healthcare Materials. e2301139. PMID 37450342 DOI: 10.1002/adhm.202301139 |
0.537 |
|
| 2023 |
Davis JT, Ghosh TM, Mazumder S, Mitra A, Bird RC, Arnold RD. Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences. 24. PMID 37239838 DOI: 10.3390/ijms24108490 |
0.574 |
|
| 2019 |
Ghosh TM, Mitra AK, Davis J, Cummings B, Yates C, Arnold R. Abstract LB-267: Transcriptomic and epigenomic analysis of metastatic castration-resistant prostate cancer and a pan-cancer analysis of its genetic signatures Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Lb-267 |
0.531 |
|
| 2019 |
Davis J, Ghosh TM, Jasper L, Eggert M, Warner J, Cummings B, Arnold R. Abstract 32: Development of a three-dimensional spheroid model system to more accurately evaluate schedule dependent mechanistic differences between metronomic and conventional dosing of topotecan Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-32 |
0.409 |
|
| 2019 |
Ghosh TM, Davis J, Barnett GS, Skarupa E, Warner JD, Cummings BS, Arnold RD. Abstract 2944: Identification of key transcriptomic and epigenomic factors influencing conventional and metronomic dosing in aggressive and non-aggressive prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2944 |
0.625 |
|
| 2014 |
Lamba JK, Fridley BL, Ghosh TM, Yu Q, Mehta G, Gupta P. Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics. 15: 1565-74. PMID 25340731 DOI: 10.2217/Pgs.14.107 |
0.323 |
|
| 2014 |
Fridley BL, Ghosh TM, Wang A, Goode EL, Lamba J. Abstract 5565: In vitro pharmacogenomic study of ovarian cancer finds novel genetic variants associated with response to platinum and taxane therapies Cancer Research. 74: 5565-5565. DOI: 10.1158/1538-7445.Am2014-5565 |
0.382 |
|
| 2014 |
Ghosh TM, Feldberg TJ, Bhise N, Lamba JK. Abstract 5562: Screening ofin vitrocytotoxicity of nucleoside analogs in HapMap cell lines to identify predictive markers of drug sensitivity Cancer Research. 74: 5562-5562. DOI: 10.1158/1538-7445.Am2014-5562 |
0.329 |
|
| 2014 |
Lamba JK, Fridley BL, Ghosh TM, Yu Q, Mehta G, Gupta P. Abstract 5554: Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small cell lung cancer Cancer Research. 74: 5554-5554. DOI: 10.1158/1538-7445.Am2014-5554 |
0.334 |
|
| 2013 |
Chauhan L, Fridley B, Tanya F, Ghosh TM, Bhise N, Lamba J. Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H-Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines Blood. 122: 1287-1287. DOI: 10.1182/Blood.V122.21.1287.1287 |
0.316 |
|
| 2013 |
lamba JK, Feldberg T, Ghosh TM, Bhise N, Fridley B. Abstract 2214: Genome-wide association analysis identified genetic markers associated with triptolide cellular sensitivity using HapMap LCLs as model system. Cancer Research. 73: 2214-2214. DOI: 10.1158/1538-7445.Am2013-2214 |
0.308 |
|
| Show low-probability matches. |